IgA nephropathy treatment with traditional Chinese medicine: A case report

被引:2
作者
Zhang, Ying-Yu [1 ,2 ]
Chen, Yan-Lin [1 ,2 ]
Yi, Lan [1 ,2 ,3 ]
Gao, Kun [1 ,2 ,3 ]
机构
[1] Nanjing Univ Chinese Med, Div Nephrol, Affiliated Hosp, 155 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China
[2] Jiangsu Prov Hosp Chinese Med, Div Nephrol, Nanjing 210029, Jiangsu, Peoples R China
[3] Nanjing Univ Chinese Med, Inheritance Studio Chinese Med Master Yan Qin Zou, Affiliated Hosp, Nanjing 210029, Jiangsu, Peoples R China
关键词
Traditional Chinese medicine; IgA nephropathy; Primary glomerular disease; Case report; DISEASE; HERBS;
D O I
10.12998/wjcc.v10.i10.3232
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND IgA nephropathy (IgAN) is a common primary glomerular disease that leads to end-stage renal disease with poor therapy efficacy. Traditional Chinese medicine (TCM) is effective in the treatment of IgAN and has the potential to become an alternative treatment for IgAN. Professor Yan-Qin Zou is a nephropathy expert, a National Chinese Medicine Master, and an heir to the Menghe School of Medicine. CASE SUMMARY A 28-year-old man had positive urinary protein and elevated serum creatinine (Scr) results and was diagnosed with IgAN 2-3 years prior to the outpatient department visit at our hospital in 2017. Professor Zou used the following methods to treat the patient: Invigorating the spleen and tonifying the kidney, removing dampness and clearing turbidity, quickening the blood and transforming stasis, and freeing vessels and regulating collaterals. She adjusted the prescription in accordance with the patient's symptoms. After 6 mo of treatment, the symptoms had resolved and serological indexes were also decreased [Scr from 288.5 to 188.6 mu mol/L, blood urea nitrogen (BUN) from 10.9 to 9.5 mmol/L, serum uric acid (UA) from 612 to 503 mu mol/L]. During follow-up, BUN, Scr, and UA levels remained stable. CONCLUSION Professor Zou's therapeutic strategy to treat IgAN using TCM was efficacious and a good reference for application.
引用
收藏
页码:3232 / 3240
页数:9
相关论文
共 25 条
[1]  
Ammirati AL, 2020, REV ASSOC MED BRAS, V66, pS3, DOI [10.1590/1806-9282.66.S1.3, 10.1590/1806-9282.66.s1.3]
[2]   The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification [J].
Cattran, Daniel C. ;
Coppo, Rosanna ;
Cook, H. Terence ;
Feehally, John ;
Roberts, Ian S. D. ;
Troyanov, Stephan ;
Alpers, Charles E. ;
Amore, Alessandro ;
Barratt, Jonathan ;
Berthoux, Francois ;
Bonsib, Stephen ;
Bruijn, Jan A. ;
D'Agati, Vivette ;
D'Amico, Giuseppe ;
Emancipator, Steven ;
Emma, Francesco ;
Ferrario, Franco ;
Fervenza, Fernando C. ;
Florquin, Sandrine ;
Fogo, Agnes ;
Geddes, Colin C. ;
Groene, Hermann-Josef ;
Haas, Mark ;
Herzenberg, Andrew M. ;
Hill, Prue A. ;
Hogg, Ronald J. ;
Hsu, Stephen I. ;
Jennette, J. Charles ;
Joh, Kensuke ;
Julian, Bruce A. ;
Kawamura, Tetsuya ;
Lai, Fernand M. ;
Leung, Chi Bon ;
Li, Lei-Shi ;
Li, Philip K. T. ;
Liu, Zhi-Hong ;
Mackinnon, Bruce ;
Mezzano, Sergio ;
Schena, F. Paolo ;
Tomino, Yasuhiko ;
Walker, Patrick D. ;
Wang, Haiyan ;
Weening, Jan J. ;
Yoshikawa, Nori ;
Zhang, Hong .
KIDNEY INTERNATIONAL, 2009, 76 (05) :534-545
[3]  
Feehally J., 2019, COMPREHENSIVE CLIN N, V6th, P270
[4]   Overview of the anti-inflammatory effects, pharmacokinetic properties and clinical efficacies of arctigenin and arctiin from Arctium lappa L [J].
Gao, Qiong ;
Yang, Mengbi ;
Zuo, Zhong .
ACTA PHARMACOLOGICA SINICA, 2018, 39 (05) :787-801
[5]   Histologic subclassification of IgA nephropathy: A clinicopathologic study of 244 cases [J].
Haas, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (06) :829-842
[6]   Dapagliflozin in Patients with Chronic Kidney Disease [J].
Heerspink, Hiddo J. L. ;
Stefansson, Bergur V. ;
Correa-Rotter, Ricardo ;
Chertow, Glenn M. ;
Greene, Tom ;
Hou, Fan-Fan ;
Mann, Johannes F. E. ;
McMurray, John J. V. ;
Lindberg, Magnus ;
Rossing, Peter ;
Sjostrom, C. David ;
Toto, Roberto D. ;
Langkilde, Anna-Maria ;
Wheeler, David C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15) :1436-1446
[7]   Traditional Uses, Origins, Chemistry and Pharmacology of Bombyx batryticatus: A Review [J].
Hu, Meibian ;
Yu, Zhijie ;
Wang, Jiaolong ;
Fan, Wenxiang ;
Liu, Yujie ;
Li, Jianghua ;
Xiao, He ;
Li, Yongchuan ;
Peng, Wei ;
Wu, Chunjie .
MOLECULES, 2017, 22 (10)
[8]   Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies [J].
Li, LS ;
Liu, ZH .
KIDNEY INTERNATIONAL, 2004, 66 (03) :920-923
[9]   Chemical constituents, clinical efficacy and molecular mechanisms of the ethanol extract ofAbelmoschus manihotflowers in treatment of kidney diseases [J].
Li, Nan ;
Tang, Haitao ;
Wu, Liang ;
Ge, Haitao ;
Wang, Yurong ;
Yu, Honglin ;
Zhang, Xiuli ;
Ma, Jimei ;
Gu, Harvest F. .
PHYTOTHERAPY RESEARCH, 2021, 35 (01) :198-206
[10]   Total Extracts of Abelmoschus manihot L. Attenuates Adriamycin-Induced Renal Tubule Injury via Suppression of ROS-ERK1/2-Mediated NLRP3 Inflammasome Activation [J].
Li, Wei ;
He, Weiming ;
Xia, Ping ;
Sun, Wei ;
Shi, Ming ;
Zhou, Yao ;
Zhu, Weiwei ;
Zhang, Lu ;
Liu, Buhui ;
Zhu, Jingjing ;
Zhu, Yiye ;
Zhou, Enchao ;
Sun, Minjie ;
Gao, Kun .
FRONTIERS IN PHARMACOLOGY, 2019, 10